Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

作者: Roger P. Bakale , Karim Lalji , Surendra P. Singh , Judy Caron , H. Scott Wilkinson

DOI:

关键词: PharmacologyAnxietyPsychiatryCognitionSedativeMood disordersMenopauseMoodPsychologyEszopiclone

摘要: One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used treat, e.g., menopause, mood disorders, anxiety cognitive disorders. The first component composition is a sedative eszopiclone. second trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine. also method treating perimenopause, and

参考文章(24)
W. E. G. Müller, S. Perovic, Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Drug Research. ,vol. 45, pp. 1145- 1148 ,(1995)
Tushar Misra, Gary Maier, Judy Caron, Randall S. Wagner, Seth C. Hopkins, Mark A. Varney, Treatment of anxiety with eszopiclone ,(2007)
Roger P Bakale, Surendra P Singh, Hang Zhao, Charles P Vandenbossche, Stefan G Koenig, Scott H Wilkenson, Preparation of chiral amides and amines ,(2007)
Steven Brandt, James W. Young, Methods and compositions for treating disorders, using optically pure (+) zopiclone Official Gazette of the United States Patent and Trademark Office Patents. ,(1998)